Indications
Dosing Guide
Practical Management
Prescribing Information
Resources
Country Selection
XARELTO GLOBAL
Indications
Dosing Guide
Practical Management
Practical Management
Responsible Use
Prescriber Aid
Q&A
Bleeding Management
Prescribing Information
Resources
Resources
Major Studies
XareltoTUBE
Patient Information
Country Selection
Brazil
Canada
Denmark
France
Germany
Hungary
Japan
Netherlands
Norway
Switzerland
Spain
Sweden
United Kingdom
United States of America
Home
keyboard_arrow_right
Resources
keyboard_arrow_right
XareltoTUBE
XareltoTUBE
Atrial Fibrillation Explained
Atrial Fibrillation Explained
Cancer-Associated Thrombosis: Minimizing the Burden of In...
Cancer Associated Thrombosis or CAT treatment without the burden of injection; Your patients with cancer-associated thrombosis need an ef...
DVT can lead to PE
EINSTEIN JUNIOR – Study Explainer
Overview of the EINSTEIN JUNIOR trial and its main outcomes.
VTE Treatment and Renal Impairment
PE/ DVT or VTE treatment initiation and treatment extension for patients with renal impairment; Patients with renal impairment are at hig...
Why a Blood Clot is Serious
XANTUS Webcast 2015: Xarelto for Prevention of Stroke in ...
XANTUS: Low Rates of Bleeding and Stroke in a Real-World Prospective, Observational Study of Patients Treated with Rivaroxaban for Stroke...
Xarelto Renal Explainer Video
Xarelto Versus Aspirin for Extended Treatment of VTE: Rat...
Summary of EINSTEIN CHOICE trial of Xarelto for extended treatment of venous thromboembolism
